Please assess the completion status of the following clinical trial:

Trial Title: Oral Carnitine for Cramps in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Age 16 or older~* Gestational Age 12 to 33 weeks~* Occurrence of muscle cramps at least once weekly~* Ability to tolerate oral L-Carnitine~* Ability / willingness to provide informed consent in English or Spanish~Exclusion Criteria:~* Prior treatment for muscle cramps during this pregnancy~* Chronic muscle cramps prior to pregnancy~* Magnesium administration beyond that contained in prenatal vitamins~* History of seizures~* History of Pre-term delivery before 36 weeks gestational age~* Inability to tolerate oral L-Carnitine (e.g. hyperemesis gravidarum)~* Inability or unwillingness to provide informed consent

- Gender: FEMALE
- Minimum Age: 16 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- I (Type: EXPERIMENTAL): Oral L-Carnitine, 1g PO twice daily
- II (Type: PLACEBO_COMPARATOR): Placebo, similar in appearance to experimental drug, given orally twice daily.

Based on this trial design, predict the completion outcome and termination type (if applicable).